India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
National News Supreme Court Extends Mandatory Third-Party Insurance Period for New Vehicles The Supreme Court…
India is one of the biggest producers of tomatoes in the world and second to…
Tewolde Gebremariam, formerly the Chief Executive Officer of Ethiopian Airlines, has been named as the…
Reserve Bank of India (RBI) has stated that it is planning to start issuing polymer…
Railways have been very significant in joining distant areas and boosting trade, tourism, and development.…
Uttar Pradesh Private Business Park Development Scheme, 2025 is an important scheme that has been…